Department of Surgery, Prisma Health-Upstate, Greenville, SC, USA.
Department of Surgery, Division of Minimal Access, University of South Carolina School of Medicine, Greenville, SC, USA.
Am Surg. 2020 Nov;86(11):1602-1606. doi: 10.1177/0003134820942207. Epub 2020 Aug 24.
Increased recognition of the dangers of opioid analgesia has led to significant focus on strategies for reducing use through multimodal analgesia, enhanced recovery protocols, and standardized guidelines for prescribing. Our institution implemented a standard protocol for prescribing analgesics at discharge after ventral hernia repair (VHR). We hypothesize that this strategy significantly reduces opioid use.
A standardized protocol for discharge prescribing was implemented in March 2018. Patients were prescribed ibuprofen, acetaminophen, and opioids based on milligram morphine equivalent (MME) use the 24 hours prior to discharge. We retrospectively reviewed prescriptions of opioids for two 6-month periods-July-December 2017 (PRE) and July-December 2018 (POST)-for comparison using EPIC report and the South Carolina Prescription Monitoring Program. Analysis performed included Mann-Kendall linear trend test and Student's -test for continuous variables.
VHR was performed in 105 patients in the PRE and 75 patients in the POST group. Total MME prescribed decreased significantly from mean 322.7 + 261.3/median 225 (IQR 150-400) MME to 141.6 + 150.4/median 100 (50-184) MME ( < .001). This represents a 57% reduction in mean opioid MME prescriptions. Acetaminophen prescribing increased from 10% to 65%, and ibuprofen from 7.6% to 61.3%. Refills were prescribed in 21 patients (20%) during the PRE period, which decreased to 10.7% during the POST group ( = .141). Implementation of an evidence-based protocol significantly reduces opioid prescribing after VHR.
A multimodal approach to postoperative pain management decreases the need for opioids. The additional implementation of an evidence-based prescribing protocol results in significant reduction of opioid use following VHR.
人们越来越认识到阿片类镇痛药的危险,因此高度重视通过多模式镇痛、强化康复方案以及制定标准化的处方指南来减少其使用。我们医院在腹侧疝修补术(VHR)后出院时实施了一种阿片类药物处方标准方案。我们假设这种策略可显著减少阿片类药物的使用。
2018 年 3 月实施了一种出院时处方标准方案。根据患者出院前 24 小时的吗啡等效剂量(MME)使用量,开具布洛芬、对乙酰氨基酚和阿片类药物。我们使用 EPIC 报告和南卡罗来纳州处方监测计划回顾性比较了 2017 年 7 月至 12 月(PRE)和 2018 年 7 月至 12 月(POST)两个 6 个月期间的阿片类药物处方。分析包括 Mann-Kendall 线性趋势检验和 Student's t 检验用于连续变量。
PRE 组有 105 例患者和 POST 组有 75 例患者接受了 VHR。从平均 322.7±261.3/中位数 225(IQR 150-400)MME 降至平均 141.6±150.4/中位数 100(50-184)MME( <.001),总 MME 处方显著减少。这代表平均阿片类 MME 处方减少了 57%。对乙酰氨基酚的处方从 10%增加到 65%,布洛芬从 7.6%增加到 61.3%。PRE 期间有 21 例患者(20%)开具了再处方,而 POST 组减少至 10.7%( =.141)。实施基于证据的方案可显著减少 VHR 后阿片类药物的使用。
多模式术后疼痛管理方法减少了对阿片类药物的需求。额外实施基于证据的处方方案可显著减少 VHR 后的阿片类药物使用。